Paloma Partners’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-244,275
Closed -$2.2M 2156
2018
Q2
$2.2M Buy
+244,275
New +$2.19M 0.04% 405
2017
Q2
Sell
-15,938
Closed -$133K 2564
2017
Q1
$133K Buy
+15,938
New +$125K ﹤0.01% 1892
2016
Q4
Sell
-38,411
Closed -$393K 2257
2016
Q3
$393K Buy
38,411
+1,544
+4% +$17.1K ﹤0.01% 1511
2016
Q2
$416K Buy
+36,867
New +$462K ﹤0.01% 1624
2015
Q4
Sell
-26,379
Closed -$415K 2036
2015
Q3
$415K Buy
26,379
+1,677
+7% +$33.9K 0.01% 1131
2015
Q2
$501K Buy
+24,702
New +$566K 0.01% 1086
2014
Q4
Sell
-326,873
Closed -$6.34M 1482
2014
Q3
$6.34M Buy
326,873
+300,561
+1,142% +$6.55M 0.29% 77
2014
Q2
$608K Buy
+26,312
New +$643K 0.02% 508

Paloma Partners's KND Position: Q3 2018 in Review

Paloma Partners sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 244,275 shares — an estimated $2.2M sold.

Paloma Partners first reported a position in KND in Q2 2014 and held it in 8 quarters. The position peaked at $6.34M in Q3 2014. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Paloma Partners reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Paloma Partners sold 244,275 Kindred Healthcare shares in Q3 2018, an estimated $2.2M.
  • Paloma Partners first reported a position in Kindred Healthcare in Q2 2014 and held it in 8 quarters.
  • Paloma Partners's Kindred Healthcare position peaked at $6.34M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.